BREMELANOTIDE is a pharmaceutical substance primarily used for the treatment of female sexual dysfunction. Its chemical name is “Ac-Nle-c[Asp-His-(D-Phe)-Arg-Trp-Lys]-OH” and its CAS number is 189691-06-3.
BREMELANOTIDE is a synthetic peptide that acts as a melanocortin receptor agonist. It specifically targets the melanocortin receptor 4 (MC4R), which is involved in regulating sexual arousal and desire in the brain. By activating the MC4R, BREMELANOTIDE enhances sexual desire and arousal in women, particularly those with hypoactive sexual desire disorder.
This pharmaceutical substance is typically administered as a subcutaneous injection. It is currently under development and evaluation for its safety and efficacy in treating female sexual dysfunction. BREMELANOTIDE has shown promising results in clinical trials, with improved sexual desire and satisfaction reported among the patients.
However, it is important to note that as with any pharmaceutical substance, BREMELANOTIDE may have potential side effects
